Entrada Therapeutics (TRDA) insider trading in the last 6 months

One insider bought $29K, 3 sold $5.5M.

Quality Score-6Poor

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See all 18 tradesSee it live, free until Thursday morning. No account. No card. Then keep going with a free account.

Form 4 filings, newest first

SellMPM Bioventures 2018, L.P.$1.4M10% ownerat $7.41 on Sep 8, filed Sep 9

SellMPM Bioventures 2018, L.P.10% owner$1.4Mat $7.41 on Sep 8, filed Sep 9

SellMPM Bioventures 2018, L.P.$274K10% ownerat $7.11 on Sep 4, filed Sep 9

SellMPM Bioventures 2018, L.P.10% owner$274Kat $7.11 on Sep 4, filed Sep 9

SellMPM Bioventures 2018, L.P.$206K10% ownerat $7.13 on Sep 9, filed Sep 9

SellMPM Bioventures 2018, L.P.10% owner$206Kat $7.13 on Sep 9, filed Sep 9

From SEC Form 4s, the newest filed Sep 9, 2026 · Insiders have 2 business days to file a trade

15 more filings on TRDA in the last 6 months, for Pro members. See them free →

Pro members see every filing on TRDA with what each insider bought or sold and at what price, and can turn on an optional alert when an insider buys.

Who files at Entrada Therapeutics

Insider trades by person

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

Questions about TRDA's insider trades

As of Nov 10, 2026: Entrada Therapeutics (TRDA) has 18 insider filings on record in the last 6 months, the newest filed Sep 9, 2026. Its Quality Score is -6 (Poor). Scores as of 11:35 PM ET, 15 minutes behind.

Are TRDA insiders buying or selling?

One insider bought $29K across 1 filing, and 3 insiders sold $5.5M across 17 filings, in the last 6 months. The newest filing: MPM Bioventures 2018, L.P., 10% owner, sold $1.4M on Sep 8, 2026.

Who are TRDA's biggest insider sellers?

By the dollars of their sales in the last 6 months: MPM Bioventures 2018, L.P. (10% owner), 6 sales; Kush Parmar (Director), 5 sales; MPM BioVentures 2014, L.P. (10% owner), 6 sales.

When did a TRDA insider last buy?

Bernhardt G. Zeiher, Director, bought TRDA shares on May 20, 2026, filed May 21, 2026, the newest insider buy on record.

Entrada Therapeutics's page has its Quality Score, its chart, and its earnings. More in Healthcare and Biotech.

Entrada Therapeutics (TRDA) insider trading in the last 6 months

Form 4 filings, newest first

Who files at Entrada Therapeutics

Questions about TRDA's insider trades

Every insider trade, with its stock's score.